News in brief

Sabinsa awarded $850,000 in curcuminoids patent suit

By Hank Schultz contact

- Last updated on GMT

Sabinsa awarded $850,000 in curcuminoids patent suit
Sabinsa Corporation has prevailed in a patent infringement lawsuit against an Indian competitor based on the intellectual property supporting its Curcumin C3 Reduct technology.

Sabinsa, which is based in Bangalore, India with other bases of operations in India as well as in New Jersey and Utah, supplies a variety of botanical extracts and fine chemicals.  The company has been a leader in the development of curcuminoid ingredients.  It sources its raw material for these and other botanicals from a bevy of small holder farmers in India and elsewhere.

Success breeds imitators

The burgeoning popularity of curcuminoid ingredients has brought many competitors into the market, some of whom are not playing by the rules as far as Sabinsa is concerned. After a lengthy patent dispute with competitor Olive Lifesciences Pvt. Ltd. the United States District Court in New Jersey entered a judgment on April 5 awarding Sabinsa more than $850,000 in damages, enhanced damages, attorney’s fees, costs, and interest.

 The company had first filed the suit on June 8, 2016. It covers Sabinsa’s US Patent No. 6,653,327 covering Sabinsa’s novel methods and formulations for tetrahydrocurcuminoids (THCs).

According to Sabinsa, the judgment concludes that the ’327 Patent is valid, enforceable, and properly issued by the U.S. Patent and Trademark Office.  Sabinsa has patents related to THCs in the United States, Europe, Australia, New Zealand, and other locations.  In the United States, Sabinsa has successfully litigated willful infringement of the ’327 patent and has obtained judgments against other infringers.

“As a pioneer in the industry, Sabinsa has researched and developed many innovative products used by the nutritional supplement industry,”​ said Sabinsa’s founder Dr. Muhammed Majeed.  “The success has spawned many imitators, and Sabinsa will not hesitate to enforce its patents and other intellectual property.”

Olive Lifesciences did not respond in time for publication to a request for comment.

Related news

Show more

Related products

show more

ApplePhenon Paper by Renowned Dr William Sears, MD

ApplePhenon Paper by Renowned Dr William Sears, MD

BGG (Beijing Gingko Group) | 13-Oct-2020 | Technical / White Paper

Dr. William Sears, author of over 40 best-selling books and world-renowned media health expert, lends his pen to one of the most exciting ingredients to...

Going Organic: a new chapter in supplements

Going Organic: a new chapter in supplements

INNOBIO Corporation Limited | 12-Oct-2020 | Data Sheet

"Organic" is more of a healthy lifestyle. Rising consumer awareness of organic products and widening availability are two major drivers of global...

How a Vitamin Can Break the Calcium Curve

How a Vitamin Can Break the Calcium Curve

NattoPharma USA, Inc. | 12-Oct-2020 | Technical / White Paper

Arteries stiffness is measured by pulse wave velocity (PWV), which increases throughout everyone's lifespan, typically from about 5 in your 30s to...

Fermented Soy for Relief of Heartburn Symptoms

Fermented Soy for Relief of Heartburn Symptoms

Lallemand Bio-Ingredients | 08-Oct-2020 | Clinical Study

Gastro-AD® is a food supplement based on non-GMO soy fermented by Lactobacillus strain L. delbrueckii R-187 (Rosell-187). It has an excellent track record...

Related suppliers

Follow us


View more